Skip to main content

pregnancy Archives

Grant bolsters research to address rising maternal mortality rates

Oct. 27, 2023—Study seeks to better understand the mechanism behind the association between preeclampsia and other hypertensive disorders of pregnancy and cardiovascular disease.

Read more


Maternal diet influences postnatal diabetes risk

Jun. 13, 2023—Studies in a primate animal model suggest that islet hyperfunction — which in humans is associated with increased fat mass and Type 2 diabetes — is programmed in offspring by a maternal Western-style diet during pregnancy.

Read more


Study seeks to identify prenatal allergy risk markers

Mar. 16, 2023—A Vanderbilt clinical trial is seeking to identify prenatal and early childhood markers of high risk for food allergy and atopic dermatitis, or eczema, as well as biological pathways that lead to these conditions.

Read more


Penicillin allergy test recommended for pregnant women

Feb. 16, 2023—Vanderbilt experts say getting rid of unnecessary penicillin allergy labels allows women to receive better treatments for common infections during pregnancy and delivery.

Read more


Study to explore nasal bacteria of children born by C-section

Nov. 10, 2022—Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.

Read more


Targeted cancer drug during pregnancy

Aug. 2, 2022—The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.

Read more


Study shows two vaccine doses for mothers eases COVID complications for infants

Jul. 6, 2022—Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.

Read more


Rheumatoid arthritis: special deliveries

Mar. 28, 2022—Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.

Read more


Invasive strep can defy zinc toxicity

Feb. 28, 2022—Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.

Read more


Common questions about COVID vaccine and pregnancy

Nov. 15, 2021—  Recently, Vanderbilt University Medical Center’s Chief Epidemiologist, Dr. Tom Talbot, sat down to speak with his colleague Dr. Milner Staub, one of VUMC’s Adult Infectious Diseases specialists, about COVID vaccines, pregnancy and fertility. Staub, who is pregnant and has been vaccinated for COVID, answered important questions about issues and misperceptions associated with pregnancy and...

Read more


HCV infection among pregnant people increasing

Oct. 29, 2021—  by Emily Stembridge Hepatitis C virus (HCV) infection can lead to long-term health problems including liver damage, liver failure, cirrhosis, liver cancer and even death. These outcomes are especially dangerous for pregnant people and their babies. The leading cause of HCV in the U.S. is injection drug use as a result of opioid use...

Read more


Fibroids and preterm birth

Sep. 30, 2021—In a large, prospective study, Vanderbilt researchers found no association between fibroids and any clinical subtype of preterm birth, supporting a reconsideration of the impression that fibroids increase preterm birth risk.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more